7Blumberg N,Heal JM,Cowles JW,et al.Leukocyte-reduced transfusions in cardiac surgery results of an implementation trial[J].Am J Clin Pathol,2002,118 (3):376-381.
8Shinar E,Prober G,Yahalom V,et al.WBC filtration of whole blood after prolonged storage at ambient temperature by use of an in-line filter collection system[J].Transfusion,2002,42 (6):734-737.
9Taniguchi K,Kobayashi M,Harada H,et al.Human neutrophil antigen-2α expression on neutrophils from healthy adults in western Japan[J].Transfusion,2002,42 (5):651-657.
10Flesch BK,Neppert J.Transfusion2related acute lung injury caused by human leucocyte antigen class Ⅱ antibody[J].Br J Haematol,2002,116 (3):673-676.
6Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase.4 gene becomes restricted to lymphatic endothelium during development [J]. Proe Natl Aead Sei USA, 1995, 92(8):3566-3570.
7Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Fit4(VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases[J]. EMBOJ, 1996,15(2) :290-298.
8Oh SJ, Jeltsch MM, Birkenhager R, et al. VEGF and VEGFC: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane [J]. Dev Biol, 1997, 188(1):96-109.
9Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer [J]. Clin Cancer Res, 1999,5(7):1823-1829.
10Dzik H. Walter. Leukoreduced blood components: laboratory and clinical aspects. In: Rossi CE, Simon TL, Moss GE, et al. Principle of transfusion Medicine (2nd edition ). Media,Maple press company,1996,353.
